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ABSTRACT 
Introduction: Although the Brief Psychiatric Rating Scale (BPRS) is widely used for evaluating patients with schizo- 
phrenia, the meaning of the weights of the individual symptoms is ambiguous. The aims of the study were 1) to investi- 
gate whether the modification of relative weights of items of the BPRS is able to enhance its correlation with the Clini- 
cal Global Impression-Schizophrenia scale (CGI-SCH) and 2) to construct a potential modified BPRS. Methods: We 
evaluated 200 schizophrenia patients using the BPRS and the CGI-SCH and drew the scatter plot distributions of the 
two scales. Next, univariate regression for the CGI-SCH using individual symptoms of the BPRS was performed. Mul- 
tivariate regression utilizing the “logistic function” was then conducted to allocate marks to each item and Pearson’s r 
correlation coefficient and r-squared between the two scales were assessed. After that, we constructed an example of a 
potential modified BPRS. Results: With the scatter plot for the two scales, a logarithmic curve was obtained; this was 
described by [CGI-SCH] = 3.2248 × ln[18-item BPRS] – 7.2044 (p < 0.001). Pearson’s r for the relationship between 
the scales was 0.8216 and r-squared was 0.7718 (both p < 0.001). The univariate regression indicated a positive associa- 
tion between all symptoms of the BPRS and the CGI-SCH, although some of them were significant (p < 0.05) and oth- 
ers were not (p ≥ 0.05). Multivariate regression utilizing a logistic function provided the values “Pi” that could express 
the relative weights of individual symptoms. Subsequently, modification of point allocations according to “Pi” yielded a 
Pearson’s r of 0.8491 and an r-squared of 0.7718 (not changed) (both p < 0.001). An example of a potential modified 
BPRS was constructed. Conclusions: Within the limits of our data, the weightings of items of the BPRS improved the 
correlation of the BPRS with the CGI-SCH for evaluating schizophrenia. 
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1. Introduction 
Schizophrenia is a serious mental disorder characterized by 
a number of symptoms. To evaluate the effects of treatment 
for schizophrenia, it is important to assign quantitative 
values to the symptoms. Many rating scales have been 
used to evaluate various symptomatic domains in schizo- 
phrenia [1]. This has led to confusion regarding the suit- 
ability of the different scales available, not only for 
evaluation and treatment of the disease but also in re- 
search and clinical studies of the effects of medication. 
Currently, consensus is lacking about which rating scales 
are most appropriate for evaluating schizophrenia. Evalua- 
tion scales that are relevant, quick, user-friendly, gradu- 
ated at equal intervals and with high linearity are needed 
to facilitate measurement-based treatment of schizophre- 
nia. Conventionally, we often utilize the evaluation scales  
for mental disease as if there were a perfect linear rela- 
tionship between the scores and the global state of illness. 
However, it is uncertain that these scales have perfect 
linearity and that they reflect the true states of patients 
with schizophrenia. The Brief Psychiatric Rating Scale 
(BPRS) [2] is one of the standard instruments used most 
frequently in daily practice for evaluating the severity of 
schizophrenia. Other than the BPRS, also popular are the 
Clinical Global Impression-Schizophrenia scale (CGI- 
SCH) [3], the Positive and Negative Syndrome Scale 
(PANSS) [4], the Scale for Assessment of Positive Symp- 
toms (SAPS) [5] and the Scale for Assessment of Nega- 
tive Symptoms (SANS) [6]. Although the BPRS includes 
18 items and the allocation of marks is defined clearly, as 
all items have the same range of marks (from 1 (not pre- 
sent) to 7 (extremely severe), with “0” meaning “not as-  
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sessed”), it is not unusual to find that scores for the BPRS 
differ widely in proportion from those for the CGI-SCH 
in the same patient. 
Ideally, scores from one scale could be mapped di- 
rectly onto the other, making it possible to compare indi- 
viduals evaluated with one scale or the other. We decided 
to investigate this divergence analytically, looking at the 
clinical weights of various symptoms (the relative mag- 
nitudes of symptoms in schizophrenia) and the issue of 
scale nonlinearity. It was discussed in our previous report 
that there might not be a linear relationship between the 
two scales (the shape of distribution between them was 
assumed to be a logarithmic curve) and that the degree of 
linearity between the BPRS and the CGI-SCH might be 
influenced not only by the former’s selection of items but 
also by modification of the points allocated to each 
symptom [7]. However, there was a crucial weakness in 
this analysis as some items of the BPRS were excluded. 
This method probably caused various biases in the results, 
which we are now attempting to correct. This time, our 
aim was to examine whether the modification of the 
point allocations apart from selection of items (if possi- 
ble, using the same number of items, 18) enhanced the 
degree of the linearity of the BPRS with the CGI-SCH. 
We believe that, for all evaluation scales, the determina- 
tion of items is most important for precise evaluation of 
the patient’s state. There are many reports examining 
which items should be selected for the adequate compo- 
sition of a scale, not only in the fields of psychiatry but 
also in other fields of medicine. However, there are few 
studies that have investigated whether the weights of 
symptoms of the BPRS were related to the global state of 
mental illness (as measured by the CGI-SCH) and whether 
there was a possibility that modification of these weights 
in the BPRS rather than an altered selection of items 
could enhance its correlation with the CGI-SCH score 
utilizing a multivariate regression method, particularly, 
utilizing a logistic function. 
The aims of the present study were: 1) to confirm 
whether a modification of point allocation to individual 
items rather than a selection of items is able to enhance 
the degree of correlation of the 18-item BPRS with the 
CGI-SCH global impression of the severity of schizophre- 
nia, utilizing non-linear multivariate regression analysis 
(not with the maximum-likelihood method but with the 
least-squares method) with a logistic function; and 2) to 
consider an example of a potential modified BPRS that 
expresses relative weights of respective symptoms and 
would be expected to have improved correlation with the 
CGI-SCH scores compared with the original 18-item 
BPRS. 
2. Methods 
2.1. Participants 
This was a retrospective study of outpatients and inpa- 
tients treated at the Tokyo Women’s Medical University, 
Miyazaki Hospital and Depression Prevention Medical 
Center, Kyoto Jujo Rehabilitation Hospital, Japan, who 
met the DSM-IV-TR [8] criteria for schizophrenia. A 
total of 200 patients (99 males, 101 females) with a mean 
age of 45.13 years (range, 16 - 83) were included in this 
study. Fifty patients were suffering their first episode of 
schizophrenia or attending for initial treatment (Group A) 
and 150 were randomly selected during either the acute 
or chronic phase of schizophrenia (Group B). The study 
involved a retrospective chart review and was approved 
by the ethics committee of our institution. 
2.2. Research Design 
All patients were evaluated and rated from their medical 
records using the BPRS and the CGI-SCH during the 
same session, but at the initial consultation for Group A 
and at a random treatment session for Group B. In this 
study, we utilized the CGI-SCH as a scale that substi- 
tuted for the evaluation made by the patients’ psychia- 
trists, under the assumption that the CGI-SCH had per- 
fect linearity and that it represented the precise clinical 
global impression of the treating psychiatrists, in order to 
simplify the analysis. 
Two experienced psychiatrists shared their evaluations, 
and the scores for the BPRS and the CGI-SCH were pre- 
sented graphically. At this stage, we examined the dis- 
tribution on a scatter plot of the two scales and, if the 
linearity of the BPRS to the CGI-SCH was not initially 
apparent, we aimed to express the relationship in a more 
precise mathematical equation. Next, univariate linear 
regression analysis was performed with the CGI-SCH as 
the dependent variable and with individual symptoms of 
the BPRS as the independent variables. We examined 
whether the relationship between an individual symptom 
of the BPRS and the CGI-SCH had a positive or negative 
correlation with or without significance. After the uni- 
variate regressions, the variables that were positively asso- 
ciated with the CGI-SCH were entered into a multivariate 
model, while those that were negatively correlated with 
the CGI-SCH were excluded from this trial regardless of 
whether they were significant (p < 0.05) or not (p ≥ 0.05). 
After that, multivariate non-linear regression analysis 
utilizing the logistic function as the regression equation 
was conducted, with the CGI-SCH as the dependent 
variable and with all 18 items of the BPRS as independ- 
ent variables. In multivariate regression, we ordinarily do 
not utilize a logistic function as a regression function in 
the “least-squares method” but in the “maximum-likelihood 
method” at which the dependent variable takes only the 
binominal number “0” or “1”, because logistic regression 
was devised for outcomes with only two states, e.g., “re- 
mission” or “non-remission” [9-14], “coronary heart dis- 
ease” or not [15-17]. 
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However, we decided to adopt a way of utilizing the lo- 
gistic function as the regression function in a “non-linear 
least-squares method” because the dependent variable of 
the CGI-SCH could take polychotomous points, ordinar- 
ily one to seven, and putting a cut-off value on the CGI- 
SCH score might cause a loss of data in terms of the raw 
distribution of the scatter plot between the BPRS and the 
CGI-SCH. Another crucial reason for this choice is that, 
with multivariate regression analyses, we often obtain 
regression coefficients of independent variables that are 
inversely associated with the dependent variable. In our 
previous study, by performing multivariate regression, 
some symptoms of the BPRS were inversely correlated 
with the CGI-SCH, although the phenomenon of the 
higher score on some symptoms implying a less ill state 
was a departure from clinicians’ experiences [7]. To be 
sure, there might be a case where independent variables 
are inversely correlated with a dependent variable in mul- 
tivariate regression, even though the independent variables 
have positive correlations in their respective univariate 
regression analyses (utilizing each variable as the only 
independent variable). However, to our knowledge, it 
seems likely that symptoms that are significantly and posi- 
tively correlated with the CGI-SCH tend to have more 
meaning for evaluating the true state of schizophrenic 
patients, and that symptoms that are insignificantly 
and/or inversely associated with the CGI-SCH tend to 
have less meaning for that. If so, by increasing the point 
allocations of the symptoms significantly and positively 
correlated with the CGI-SCH and decreasing the point 
allocations of those inversely associated with the CGI- 
SCH, we might be able to obtain a modified almost 
18-item BPRS that would have a higher correlation with 
the CGI-SCH, in other words, that might be closer to 
clinicians’ impressions than that of the original 18-item 
BPRS. If some form of modification of point allocation 
could enhance the correlation between the two scales, 
that might indicate a possibility that point allocation it- 
self is associated with the linearity of the BPRS to the 
CGI-SCH. Considering these aspects, we conducted a 
series of manipulations as below. 
Historically, the logistic function was explored in the 
Framingham study to identify risk and protective factors 
for coronary heart disease [15,16] (e.g., LDL cholesterol, 
triglycerides, blood glucose, systolic blood pressure, dia- 
stolic blood pressure, cigarettes/day, age, relative weight, 
etc.), and the methodology was based on that of Walker 
and Duncan [17], who proposed the logistic function that 
provided the advantage of the probability of occurrence 
of an event such as the presence/absence of heart failure 
in a dichotomous model. They used the logistic function 
in line with the least-squares method for estimating the 
relative weights of risk and protective factors for coro- 
nary heart disease through the rough comparison of the 
standardized coefficients obtained by multiplying partial 
regression coefficients by the individual standard devia- 
tion of the characteristic. Here, a larger standardized co- 
efficient represented a stronger risk factor, and vice versa. 
We presumed that this method might be applicable for 
enhancing the linearity of an evaluating scale such as the 
BPRS, especially to improve the relative weights of symp- 
toms. 
As it is usually known, a logistic function has a value 
between 0 and 1 and the function transforms both posi- 
tive and negative numbers that exceed “1” or are less than 
“0” into a positive number within the interval “0 - 1” ac- 
cording to its characteristic behavior on a graph (that is, an 
ascending sigmoid curve). By adjusting the size of the 
CGI-SCH score into “a ratio to 1” as “P” (0 ≤ P ≤ 1), (e.g., 
the CGI-SCH score of “2” is converted into “2/7 = 0.2857”), 
and inserting the variables of the BPRS into the logistic 
function described below, we were able to conduct non- 
linear multivariate regression analysis utilizing the logis- 
tic function as the regression function that provides val- 
ues of “P” ranging between “0 - 1” continuously. 
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(0 ≤ P ≤ 1; strictly, 0 < P < 1), –∞ < xi < +∞, i = 1 - 18, xi: 
a score of symptom of number “i” of the BPRS, usu- ally 
within 1 - 7; bi: a coefficient of the symptom of num- ber 
“i” (which is able to take a positive or negative value). 
Strictly, “P” could not take “0” or “1” exactly; however, 
this problem also occurs in the ordinal logistic function 
as the ordinal logistic regression of the maximum-like- 
lihood method. 
The “bi” terms are neither regression coefficients of lin- 
ear multivariate regression analysis nor of logistic regres- 
sion. These are coefficients that were optimized to meet 
the condition of the least-squares method, which mini- 
mizes the sum of squared differences between values ad- 
justed from the CGI-SCH score into “0 - 1” and expected 
values according to the BPRS. 
The logistic function provides the probability that the 
value of the predictor variable (symptom) of the BPRS 
will give the CGI-SCH outcome variable its full mark of 
“7”. In other words, it expresses the ratio or degree of 
share in the full score of the CGI-SCH = “7”. For exam- 
ple, P = 0.4 means a value that provides that ratio to the 
full score of the CGI-SCH “7”, indicating that the ex- 
pected score of the CGI-SCH will be 2.8 (calculated as 
0.4 × 7 = 2.8). Moreover, if the size of the partial regres- 
sion coefficient of the number-“i”-symptom, “bi”, is sig- 
nificant (p < 0.05), inserting the parameter (as xi = 7, 
where xj = 0 (j ≠ i)) utilizing “bi” (when the i-th symptom 
of the BPRS takes the full score “7” and other symptoms 
of the BPRS take nothing) provides an expected ratio Pi 
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18 variables of the BPRS
(0 ≤ Pi ≤ 1; strictly, 0< Pi < 1) that expresses how much 
the CGI-SCH score shares in its full score “7”. So, from 
a certain viewpoint, the size of “Pi” has the meaning of 
“relative weight of the i-th symptom of the BPRS” given 
by its full score to the CGI-SCH independently. There- 
fore, if a set of “Pi” terms are obtained through multivari- 
ate regression utilizing the above logistic function, we 
consider the values of the “Pi” terms as the relative weights 
of the symptoms. We are then able to evaluate the in- 
fluence of this manipulation before and after in terms of 
the degree of the linearity of the BPRS with the CGI- 
SCH. Conversely, if “bi” is not significant (p ≥ 0.05) and 
tends to become a small number, we infer that it is per- 
missible to ignore “bi”, which is then exchanged for the 
number “0”. So, we chose the way that we utilized each 
significant “bi” term from its size (Pi was calculated as = 
{1 + exp(–(b0 + bi·7))}–1) and the non-significant “bi” as 
“0” (Pi was calculated as = {1 + exp(–(b0))}–1) when we 
determined the size of “Pi” terms and whether “bi” was a 
positive number or not (Figure 1). Furthermore, if the 
results provide acceptable implications for improving the 
BPRS, by utilizing the results of multivariate regression, 
we would allocate marks in proportion to the size of “Pi” 
to individual items or symptoms. 
With regard to linearity, we then examined the distri- 
bution on the scatter plot of the BPRS and the CGI-SCH 
scores. We obtained the Pearson’s r coefficient as an indi- 
cation of the degree of linearity of the relationship between 
the two scales, r-squared being one of the values used to 
estimate the degree of the fit of the model (by observing 
how r-squared changes), before and after a series of ma- 
nipulations. Furthermore, we examined whether the modi- 
fication in this trial is able to enhance the correlation of 
the BPRS with the CGI-SCH. On the basis of the results, 
if possible, we planned to construct a prototype of a po- 
tential modified 18-item BPRS, “the modified 18-item 
 
Coef ≥0 Coef <0
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regression utilizing the logistic 
function as a regression function
Insert the respective size of the bi into the below function individually for the i-th item of the 
BPRS,  P = {1+exp(-(b0+b1∙x1+ b2∙x2+b3∙x3+…+ bi∙xi+…+b18∙x18))}-1 (i=1-18)
i) Coef ≥0 and p <0.05
insert xi=7, xj=0 (j≠i)
Pi={1+exp(-(b0+bi∙7))}-1
ii) Coef ≥0 or <0, and p ≥0.05
insert xi=7, xj=0 (j≠i), bi=0 
iii) Coef <0 and p <0.05
insert xi=7, xj=0 (j≠i)
 both b0 and bi are 
influential on Pi
only b0 is
influential on Pi
both b0 and bi are
influential on Pi
To assign the magnitude proportional to the size of Pis to the i-th item and compose a poten
example of a prototype of the modified BPRS
tial 
Univariate regressions
Pi={1+exp(-(b0+bi∙7))}-1Pi={1+exp(-(b0))}-1
 
Figure 1. A flow chart of the manipulation. The non-linear multivariate regression analysis utilizing the logistic function as a 
regression function after the selection of items of the BPRS with the univariate linear regressions is illustrated. For the i-th 
item where the p-value is significant (p < 0.05), the number bi is inserted into the logistic function under the condition xi = 7 
and xj = 0 (j ≠ i), while, for the i-th item where the p-value is not significant (p ≥ 0.05), the number bi is ignored because its size 
is considered less meaningful as a regression coefficient, and those coefficients are regarded as “0” except for b0. After that, Pi 
terms would be provided for each item according to the sizes and significance of regression coefficients. Multiplying Pi 
equally by an appropriate constant would be expected to yield an example of a prototype of the modified BPRS. As a fur- 
ther improved algorithm, the selection of items conditioned on whether coefficients are positive and significant (p < 0.05) is 
permissible at the first step of the algorithm. 
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BPRS”, which would express the relative weights of re- 
spective symptoms and be expected to have a higher 
correlation with the CGI-SCH within the limitations of 
the applicability for our data at this stage. We used Stata 
Release 10.0 [18] for the multivariate linear/non-linear 
regression analysis, used SPSS for Windows, version 14 
[19] for calculating the p-values of r-squared at analysis 
of variance (ANOVA), and Microsoft Excel 2003 [20] 
for plotting the graph. 
3. Results 
The sequence of the series of manipulation is presented 
as a flow chart in Figure 1. Table 1 shows the results of 
univariate linear regression analysis performed with the 
CGI-SCH score as the dependent variable and with each 
symptom in the BPRS as the independent variable. 
Within the limits of our data, each symptom by itself was 
positively correlated with the CGI-SCH score, although 
some had significance (p < 0.05) and others did not (p ≥  
0.05). Accordingly, we did not exclude any symptom 
from the BPRS through all subsequent manipulations. 
Figure 2 shows the relationship between the 18-item BPRS 
score and the CGI-SCH score (p < 0.001). Pearson’s r co- 
efficient for the relationship between the 18-item BPRS 
and the CGI-SCH was 0.8216 (p < 0.001) and r-squared 
(that of multivariate linear regression using all items of 
the BPRS) was 0.7718 (p-value of ANOVA was less 
than 0.001). On the scatter plot, there was a rough corre- 
lation where a curve with upper convexity was obtained 
and the straight-line relationship that had been thought to 
exist between the two scales was not apparent (this is 
also described in our previous report [7]). Because the 
shape of the curve was similar to a logarithmic curve, we 
performed a natural logarithmic transformation of the 
18-item BPRS total score. The curve was then modified 
to an almost linear distribution, which was described by 
the equation [CGI-SCH] = 3.2248 × ln[18-item BPRS] – 
7.2044 (p < 0.001; Figure 3). 
 
Table 1. Results of univariate linear regression using each variable of the BPRS in sequence. 
Variable Univariate Regression Coefficient Standard Error t p-Value 95% Confidence Interval 
Somatic concern 0.134296 0.102633 1.31 0.192 –0.068098 - 0.336689 
Anxiety 0.525204† 0.061410 8.55 0.000 0.404103 - 0.646305 
Emotional withdrawal 0.680804† 0.065076 10.46 0.000 0.552473 - 0.809136 
Conceptual disorganization 0.755212† 0.047434 15.92 0.000 0.661671 - 0.848753 
Guilt 0.437912* 0.168409 2.60 0.010 0.105806 - 0.770018 
Tension 0.620179† 0.057144 10.85 0.000 0.507491 - 0.732868 
Bizarre behavior 0.723666† 0.073220 9.88 0.000 0.579275 - 0.868057 
Grandiosity 0.248480 0.144781 1.72 0.088 –0.037029 - 0.533990 
Depressed mood 0.153266 0.151392 1.01 0.313 –0.145281 - 0.451814 
Hostility 0.619312† 0.066578 9.30 0.000 0.488020 - 0.750605 
Suspiciousness 0.588463† 0.051793 11.36 0.000 0.486326 - 0.690599 
Hallucination 0.548691† 0.039642 13.84 0.000 0.470516 - 0.626867 
Motor retardation 0.645614† 0.087394 7.39 0.000 0.473271 - 0.817956 
Uncooperativeness 0.712508† 0.053575 13.30 0.000 0.606856 - 0.818159 
Unusual thought content 0.616432† 0.041045 15.02 0.000 0.535491 - 0.697373 
Blunted affect 0.202363* 0.100449 2.01 0.045 0.004275 - 0.400451 
Excitement 0.569729† 0.047974 11.88 0.000 0.475124 - 0.664334 
Disorientation 0.777530† 0.182897 4.25 0.000 0.416855 - 1.138205 
*p < 0.05, **p < 0.01, †p < 0.001. Data for schizophrenic patients (n = 200); Within the limits of our data, the data indicate that each symptom by itself was 
positively correlated with the CGI-SCH score, although some had significance (p < 0.05) and others did not (p ≥ 0.05). Univariate regression coefficients and 
the p values are also shown. 
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Together with this, Pearson’s r between the ln[18-item 
BPRS] and the CGI-SCH was 0.8530 (p < 0.001). The 
results of non-linear multivariate regression analysis util- 
izing a logistic function are shown in Table 2. In Table 2, 
some symptoms were significantly and positively/nega- 
tively correlated with the CGI-SCH, and others were 
insignificantly and positively/negatively associated with 
the CGI-SCH. Intriguingly, there was a tendency for the 
symptoms that did not have significant correlation (p ≥ 
0.05) with the CGI-SCH score in the univariate linear 
regression analysis (Table 1) to have insignificant posi- 
tive associations with the CGI-SCH and/or significant 
negative associations with the CGI-SCH in the non-linear 
multivariate regression utilizing the logistic function as 
the regression function (Table 2). 
Inserting xi =7, xj = 0 (j ≠ i), with b0= –1.779568 con- 
sistently, without change for significant bi terms and with 
change (inserting bi = 0) for insignificant bi terms in the 
above logistic function provided the set of “Pi” terms 
(Table 3). Because the “Pi” terms were considered as the 
 
 
Figure 2. Scatter plot of the 18-item BPRS total score and 
the CGI-SCH score. An upper convexity curve similar to a 
logarithmic curve was evident and a linear relationship was 
not apparent. The range of the 18-item BPRS is 18 - 126, 
and that of the CGI-SCH is 1 - 7. 
 
 
Figure 3. Scatter plot of the natural logarithm of the 
18-item BPRS total score and the CGI-SCH score. After 
performing a natural logarithmic transformation on the 
18-item BPRS score, the approximately logarithmic curve 
was modified to an almost linear distribution and the in- crease 
in the natural logarithm of the 18-item BPRS total score was 
almost proportional to the increase in the CGI-SCH score. 
 
Table 2. Results of non-linear multivariate regression analysis utilizing a logistic function. 
Variable Multivariate Regression Coefficient Standard Error t p-Value 95% Confidence Interval 
Constant –1.779568† 0.185907 –9.57 0.000 –2.146392 - –1.412744 
Somatic concern –0.116784** 0.044366 –2.63 0.009 –0.204325 - –0.029243 
Anxiety 0.160431† 0.042822 3.75 0.000 0.075937 - 0.244925 
Emotional withdrawal –0.145482** 0.053187 –2.74 0.007 –0.250428 - –0.040536 
Conceptual disorganization 0.246513† 0.039939 6.17 0.000 0.167706 - 0.325320 
Guilt 0.081812 0.068298 1.20 0.233 –0.052952 - 0.216575 
Tension 0.056184 0.050869 1.10 0.271 –0.044188 - 0.156556 
Bizarre behavior 0.027406 0.054475 0.50 0.616 –0.080081 - 0.134893 
Grandiosity –0.134379* 0.054680 –2.46 0.015 –0.242271 - –0.026486 
Depressed mood –0.032677 0.060379 –0.54 0.589 –0.151814 - 0.086461 
Hostility 0.140460* 0.065680 2.14 0.034 0.010863 - 0.270056 
Suspiciousness –0.111373* 0.054806 –2.03 0.044 –0.219514 - –0.003232 
Hallucination 0.102879** 0.033222 3.10 0.002 0.037326 - 0.168432 
Motor retardation 0.098488 0.054066 1.82 0.070 –0.008192 - 0.205167 
Uncooperativeness 0.059815 0.059308 1.01 0.315 –0.057209 - 0.176839 
Unusual thought content 0.081910* 0.038581 2.12 0.035 0.005783 - 0.158036 
Blunted affect 0.120072* 0.046739 2.57 0.011 0.027849 - 0.212294 
Excitement 0.097073* 0.046417 2.09 0.038 0.005485 - 0.188662 
Disorientation 0.167273 0.096718 1.73 0.085 –0.023567 - 0.358112 
*p < 0.05, **p < 0.01, †p < 0.001. Data for schizophrenic patients (n = 200); Multivariate regression coefficients and the p values that were derived from 
non-linear multivariate regression utilizing the logistic function as the regression function are shown. 
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Table 3. The values of “Pi” terms. 
Variable Pi [inserting xi = 7, xj = 0 (j ≠ i), with  b0 = –1.779568, bi without change] 
Pi [inserting xi = 7, xj = 0 (j ≠ i), with  
b0 = –1.779568, bi with change] 
Somatic concern 0.069328* 0.069328 
Anxiety 0.341515* 0.341515 
Emotional withdrawal 0.057435* 0.057435 
Conceptual disorganization 0.486509* 0.486509 
Guilt 0.230252 0.144356 
Tension 0.200002 0.144356 
Bizarre behavior 0.169704 0.144356 
Grandiosity 0.061791* 0.061791 
Depressed mood 0.118334 0.144356 
Hostility 0.310807* 0.310807 
Suspiciousness 0.071812* 0.071812 
Hallucination 0.257421* 0.257421 
Motor retardation 0.251589 0.144356 
Uncooperativeness 0.204100 0.144356 
Unusual thought content 0.230374* 0.230374 
Blunted affect 0.281089* 0.281089 
Excitement 0.249729* 0.249729 
Disorientation 0.352365 0.144356 
*: significant (p < 0.05) bi (coefficient) in Table 2; The “Pi” terms of the middle column are obtained by inserting xi = 7, xj = 0 (j ≠ i), with b0 = –1.779568, bi 
without change in the logistic function for all symptoms whether the bi is significant or not. The “Pi” terms of the right column are obtained by inserting xi =7, 
xj = 0 (j ≠ i), with b0 = –1.779568, bi without change in the logistic function for significant symptoms and inserting xi = 7, xj = 0 (j ≠ i), with b0 = –1.779568, bi 
with change (=0) for insignificant symptoms. The “Pi” terms of the right column are expected to reflect the relative weights of symptoms. 
 
degrees of the expected ratio (0 - 1) of the CGI-SCH 
score to its full score “7”, we regarded these as clinical 
weights. Moreover, allocating marks to each of the 18 
items of the BPRS in proportion to the “Pi” term (multi- 
plying each i-th score by Pi) provided the scatter plot of 
the total score modified using “Pi” terms and the CGI- 
SCH score (p < 0.001, Figure 4), in which Pearson’s r 
was 0.8491 (p < 0.001) and r-squared was 0.7718 (p-value 
of ANOVA was less than 0.001). Through all manipula- 
tions, Pearson’s r was increased from 0.8216 to 0.8491, 
and r-squared did not change (0.7718). As a result, the 
distribution on the scatter plot of the two scales changed 
from that shown in Figure 2 to that shown in Figure 4, 
yielding a more linear relationship between “the modi- 
fied 18-item BPRS” and the CGI-SCH than was the case 
between the original 18-item BPRS and the CGI-SCH. In 
addition, we confirmed that the Pearson’s r when the 
BPRS was modified only through decreasing the magni- 
tude of those items that were significantly inversely cor- 
related with the CGI-SCH was 0.8325 (p < 0.001).  
Between Figures 2 and 4, r-squared for the linear mul- 
tivariate regression utilizing the unmodified and modified 
score of each symptom was not changed (0.7718). How- 
ever, r-squared for the multivariate non-linear regression 
analysis utilizing the logistic function as the regression 
function (with the CGI-SCH score adjusted from 1 - 7 
into 0 - 1 (as “P” where 0 ≤ P ≤ 1) as the dependent vari- 
able and with all the individual items of the BPRS as 
independent variables) was 0.9750, considerably higher 
than that for the ordinal multivariate linear regression us- 
ing the same full set of items (although a p-value was not 
able to be calculated with the SPSS & Stata programs). 
 
Figure 4. Scatter plot of the 18-item total score, modified 
using the Pi ratios and the CGI-SCH score. The score for 
each of the items was multiplied by the ratio Pi for each 
symptom. The range of the total score for the 18 BPRS 
items modified using multiple regression coefficients via the 
logistic function is 3.43 - 17.17, and that for CGI-SCH is 1 - 7. 
 
By utilizing the set of the individual “Pi” ratios, we 
composed a prototype of a potential modified 18-item 
BPRS: “the modified 18-item BPRS” (of tentative mean- 
ing, given the limits of our data at this stage) (Figure 5). 
4. Discussion 
The BPRS is one of the most frequently used standards for  
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Figure 5. An example of a potential modified 18-item BPRS. 
Marks for each item were calculated by multiplying the ratio 
Pi (relative weight of the i-th symptom of the BPRS), obtained 
as the right column of numbers in Table 3, for each of the 18 
items by 30. 
 
evaluating the psychopathology of patients with schizo- 
phrenia. Although its psychometric properties in terms of 
reliability, validity and sensitivity have been extensively 
examined [21], patients examined by clinicians are given 
different observer ratings using different criteria. On the 
other hand, assessment with the CGI-SCH is based on a 
score of 1 - 7, making it simple and relevant. The CGI- 
SCH may be as sensitive as the BPRS in detecting effi- 
cacy differences between antipsychotic drugs [22], but it 
is necessary for treatment response to be interpreted in 
the context of patient characteristics [23]. However, pa- 
tients with different characteristics but with similar 
scores are often treated similarly in clinical trials. There- 
fore, training is required for performing a standardized 
evaluation [24]. Other user-friendly assessments include 
the Revised Global Outcome Assessment of Life in 
Schizophrenia (Revised GOALS) [25], the Investigator’s 
Assessment Questionnaire (IAQ) [26] and the Targeted 
Inventory on Problems in Schizophrenia (TIP-Sz) [27], 
although they have some limitations in terms of method-
ology. We also believe that other important aspects of 
illness management should be supplemented with appro- 
priate subjective scales as necessary [28]. Nonetheless, 
there is no consensus among clinicians regarding the 
most suitable scale. To address this perplexing issue, 
more advanced investigations are necessary to devise rat- 
ing scales using some form of statistical method. 
Leaving aside the debate over whether psychopatho- 
logical severity or state can be expressed in evaluation 
scales such as the BPRS or the CGI-SCH and accepting 
the need and utility of such instruments, we focused here 
on improving the BPRS scale. We examined whether the 
more detailed assessment afforded by its point alloca- 
tions could be made proportional to the ratio “Pi”, which 
provides probabilities of the expected values that share in 
the full score of the CGI-SCH. 
Many previous attempts have been made to evaluate 
the adequacy of the BPRS from the viewpoint of which 
items should be selected because of their relevance. 
However, no study has approached this issue by ad- 
dressing how the degree of linearity of the BPRS can be 
changed by modifying the symptom weightings, using 
non-linear multivariate regression analysis (non-linear 
least-squares method). In the present study, by plotting 
the BPRS scores and the CGI-SCH scores in the form of 
a graph, the scatter plot of the 18-item BPRS and the 
CGI-SCH yielded a curve with upper convexity, thus 
de-monstrating that the relationship between the two 
scales was not linear (see Figure 2).  
Because the shape of the curve had an upper convexity 
similar to a logarithmic curve, by performing a natural 
logarithmic transformation on the 18-item BPRS score, a 
regression equation was obtained in a logarithmic form, 
as shown in Figure 3. From this result, we presumed that 
there was a possibility that an increase in the logarithm 
of the total score for all symptoms might be roughly 
proportional to the global increase in symptom severity 
observed clinically in schizophrenic patients that was 
mentioned in our previous report [7]. Also in this report, 
we presumed that the logarithmic relationship between 
the single score scale, the CGI-SCH, and the plural score 
scale, the BPRS, might be an important tool in our de- 
termination of the severity of illness (e.g., there might be 
a possibility that a clinician’s impression of the severity 
of a certain disease is approximately proportional not to 
the simple sum of respective severity of symptom ratings 
but to the logarithm of this sum). In addition, Pearson’s r 
between the ln[18-item BPRS] and the CGI-SCH was 
0.8530 (p < 0.001) (higher than that between the original 
BPRS and the CGI-SCH of 0.8216). This result might 
imply that the facility of the symptoms for explanation of 
the model was better in the former than in the latter, and 
that there might possibly be a more linear relationship 
between the log-transformed BPRS and the CGI-SCH 
than between the non-log-transformed BPRS and the 
CGI-SCH. However, the r-squared of the above non-lin- 
ear multivariate regression analysis (using the logistic 
function as the regression function, with the CGI-SCH 
score size-adjusted from 1 - 7 into 0 - 1 as the dependent 
variable and all items of the BPRS as independent vari- 
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ables) was 0.9750. This value was also two scales. To 
evaluate the clinical severity of schizophrenia, we sub- 
stituted the CGI-SCH score for the clinical impression. 
The values of Pearson’s r were slightly higher between 
“the modified 18-item BPRS” (constructed by modifica- 
tion of specific point allocation) and the CGI-SCH than 
between the original 18-item BPRS and the CGI-SCH 
without decreases of r-squared in terms of the results of 
greater than that for ordinal multivariate linear regression 
using the same full set of items (0.7718, although p-value 
could not be calculated with the SPSS & Stata programs). 
Therefore, a sigmoid function such as the logistic func- 
tion might be more suitable as a regression function than 
a simple linear function, as shown in Figure 2 (although 
we recognize that the results have applicability to only 
this trial at this stage). 
We then investigated whether modifying the allocation 
of marks could affect the linearity of the BPRS, at least 
within this trial, looking at the correlation of the BPRS 
with the CGI-SCH in terms of Pearson’s r and r-squared, 
which express one of the degrees of the fit between the 
linear multivariate regression before and after modifica- 
tion of point allocation. We inferred that because the 
shape of the scatter plot between the two scales became 
more linear after the modification of the score than be- 
fore, there was a possibility that the clinical weights 
might be related to the heightened values of Pearson’s r 
between “the modified 18-item BPRS” and the CGI-SCH. 
We presumed that there was a possibility that the weight- 
ings themselves were associated with the linearity of the 
BPRS. 
Furthermore, by assigning different weights to each 
item proportional to the “Pi” that was calculated from the 
regression coefficients, “bi”, we were able to construct an 
example of a potential modified 18-item BPRS: “the 
modified 18-item BPRS” (Figure 5). We assumed that 
the magnitude of each “Pi” represented the respective 
clinical weight of each item because the value of “Pi” 
was defined as a probability by the logistic function. We 
were also able to consider that the value of “Pi” provides 
a probability of or ratio to the full score of the CGI-SCH 
(“7”) according to the set of item scores of the BPRS. 
The scale is only a tentative example of a potential modi- 
fied BPRS subscale that we were able to construct within 
our data, and as a result, the number of items need not be 
18 consistently. 
Some problems have been reported with multivariate 
regression analysis. To compare the relative magnitudes 
of variables, the partial regression coefficients are often 
normalized using their respective standard deviations. 
However, the predictor variable is at least partially re- 
dundant with other predictors and the partial regression 
coefficient is influenced by the range of the predictor 
variable [29,30]. In addition, the relative importance of 
predictor variables is a tenuous concept and comparison 
of the importance of predictors is not always the best 
approach in multiple regression. As the individual items 
of the BPRS had the same range of marks (ordinarily, 1 - 
7), we considered that there would not be crucial dif- 
ferences in the sizes of standard deviations for predictor 
variables in this study. With this assumption, we treated 
the partial regression coefficients (“bi” terms) as if they 
expressed the value of the weight with which each 
symptom affected the score of the CGI-SCH through the 
logistic function. With each manipulation, the range of 
point allocations to each symptom before the manipula- 
tion might have to be coordinated with the same size of 
range. On the other hand, the use of standardized regres- 
sion coefficients is difficult because the values are not 
included in the logistic function and are not connected 
with the “Pi” terms directly. Perhaps, if we would use the 
standardized regression coefficients themselves, a more 
complex and/or especially technical adjustment might be 
needed for derivation of the “Pi” terms. This might then 
differ considerably from the operations that we have de- 
vised to this point. For instance, J Lee reported a method 
of covariates-adjusted rates for ordinal logistic regres- 
sion, in which inserting xi of each variable individually 
provided more adequate results (although the independ- 
ent variables were binominal) [31]. Also with reference 
to this, we utilized the magnitude of the “Pi” (calculated 
by inserting bi and xi = 7, xj = 0 (j ≠ i) into the logistic 
function) to modify the distribution of marks of the 
BPRS and to design a potential modified BPRS. Our 
method, however, does not utilize insignificant “bi” terms 
and this might cause a bias in the results. 
As for the method we used in the present study, there 
is a problem in utilizing the logistic function because it is 
a non-linear function described as P = {1 + exp(–(b0 + 
b1·x1 + b2·x2 ++ b18·x18))}–1. If the value of “Pi” was 
defined so that “Pi” provides a probability or ratio to the 
full score of the CGI-SCH of “7” according to the set of 
item scores of the BPRS, the “Pi” was not linearly related 
to the expected CGI-SCH. Ideally, to determine the 
weight of symptoms, we might have used only multivari- 
ate linear regression for keeping the equal interval/cali- 
bration of the parameter. Therefore, if “Pi” expresses the 
positive or negative correlation of each symptom with 
the CGI-SCH roughly, the absolute value of “Pi” will not 
have equal intervals or calibration. However, inserting 
the value of P not as “0 or 1” but as a decimal number 
(e.g., P = 0.30) reflecting the ratio (to the full score of the 
CGI-SCH) into the logistic function as the dependent 
variable might be expected to produce more valid results 
than those obtained with ordinal logistic regression (in- 
serting the value of P as only “0 or 1”), because permit- 
ing the use of a decimal number from 0 to 1 for the de- 
pendent value (P) utilizes the polychotomous value of the 
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CGI-SCH score, which is impossible in the dichotomous 
model. In other words, since the maximum likelihood 
method could be interpreted as a generalized least-squares 
method [11,32], we inferred that the non-linear multi- 
variate regression utilizing the logistic function could be 
viewed as one specific case of the maximum-likelihood 
method. If the manipulation used in this article was gen- 
eralized within the maximum-likelihood method, and the 
dependent variable was permitted to take a continuous 
decimal value between zero and one, we presumed that 
this might produce more generalized results than those of 
the ordinal least-squares method. 
When supplemented with this adjustment, the scatter 
plot representing the relationship between “the modified 
18-item BPRS” and the CGI-SCH showed a distribution 
proportional to the scatter plot connecting the score of 
“the 18-item BPRS” multiplied by “Pi” for each i-th item 
and the score of the CGI-SCH. This is because both have 
almost the same significance on the graph. Additional 
improvements in fit may be possible. 
The limitations of the present study should be noted. 
The first was the use of the CGI-SCH as a scale that sub- 
stituted for the evaluation made by the patients’ psychia- 
trists. The CGI-SCH is not a gold standard and there is 
no evidence that the CGI-SCH has perfect linearity; this 
was merely an assumption to allow modification of the 
BPRS under a determinate condition. For the CGI-SCH, 
only a certain degree of reliability has been reported [3, 
22,23]. Nonetheless, we thought that this kind of simpli- 
fication was unavoidable and the trade-off necessary, 
even if this assumption would sacrifice rigor to some ex- 
tent in exchange for examining the degree of an abstract 
value such as “linearity”. 
Second, there is no evidence supporting the assumption 
that the BPRS score and the CGI-SCH score obtained ret- 
rospectively by coding of the symptoms reported in the 
clinical chart would be comparable to the data obtained 
prospectively. Mullins, et al. reported the utility of the 
Brief Psychiatric Rating Scale for Children (BPRS-C) for 
transcribing narrative medical records into a standard 
quantitative form in which the medical records were the 
primary sources of information and the inter-rater reli- 
abilities were adequate in most major domains of psy- 
chopathology, the one notable exception being symptoms 
in the anxiety domain [33]. The value of Pearson’s r, 
0.8216, might be to some extent considered high. We 
presume that this was because the study was retrospec- 
tive. Therefore, some items of the BPRS might not have 
been marked, thus minimizing the distribution of the 
BPRS score. The ideal weighting of individual symptoms 
of the BPRS should be determined prospectively. How- 
ever, one of themes intended to be examined in this study 
is whether increasing the magnitudes of independent 
variables of significance (e.g., symptom scores of the 
BPRS) that are positively associated with the dependent 
variable (e.g., the CGI-SCH score) and decreasing the 
magnitudes of those are negatively correlated with the 
dependent variable could heighten the degree of the cor- 
relation (e.g., Pearson’s r) of the two data sets, such as 
the BPRS and the CGI-SCH, keeping the same number 
of variables (symptom scores of the BPRS). From this 
standpoint, our report might be regarded as an experi- 
mental case report demonstrating some degree of validity 
for this manipulation (modification of point allocations 
utilizing the logistic function). At any rate, prospectively 
randomized trials are needed in future studies. 
Third, the reproducibility of the result that all of the 
symptoms of the BPRS were positively correlated with 
the CGI-SCH using univariate linear regression is 
doubtful. As for the exclusion of any item, in general, the 
more variables we exclude from the model, the more 
r-squared tends to decrease. The selection of the subset 
for which the decrease of r-squared is smallest is pre- 
ferred so that the loss of model fit would be minimal. As 
a result, because the items were not excluded after uni- 
variate linear regression in Figure 1 and the r-squared for 
the results of multivariate regression utilizing all 18 
items did not change (0.7718), we did not address the 
problem of item selection in the present study. However, 
the true aim of this study was, if possible, to examine the 
effect of modification of point allocation alone on the 
degree of linearity (in this study, correlation between the 
two scales; e.g., Pearson’s r). As a further improved al- 
gorithm of Figure 1, after univariate regression, only 
positive and significant (p < 0.05) coefficients would be 
selected. In the further revised algorithm, the exclusion 
of items from the 18 item selection might occur in a first 
step of manipulation and different results might be ob- 
tained. This issue should be examined in a prospective 
study. 
Fourth, there may be some problems in our treatment 
of the size of coefficients. We did not regard positive 
values for insignificant coefficients (whether those were 
positive or negative) for multivariate non-linear regres- 
sion. Therefore, the size of insignificant “bi” terms was 
ignored by inserting “bi = 0”. As a result, relative point 
allocations of those insignificant items did not change 
and point allocations of items positively and significantly 
associated with the CGI-SCH score increased while those 
of negatively and significantly correlated items decreased. 
If there are few significant items after the procedure in 
Table 2, we infer that the degree of modification in this 
model is very low and that there might be some need of a 
device for adjustments. This is one of the future tasks 
that should be addressed rigorously. 
Fifth, despite the manipulations employed here, the 
degree of change in Pearson’s r was rather ambiguous. 
The increases appear slight; as a total, from 0.8216 to 
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0.8491. Moreover, it is considerably uncertain whether 
this change has statistical significance. However, from 
another viewpoint, despite the fact that the number of 
items remained the same, the degree of correlation 
(Pearson’s r) increased just slightly and this fact might 
indicate the possibility that modification of point alloca- 
tion itself might be able to heighten the correlation of the 
BPRS with the CGI-SCH. In the supplement, we con- 
firmed that the Pearson’s r (when the BPRS was modi- 
fied only through decreasing the magnitude of those 
items that were significantly inversely correlated with the 
CGI-SCH) was 0.8325, a value higher than that between 
the original 18-item BPRS and the CGI-SCH, but smaller 
than that between the fully modified 18-item BPRS and 
the CGI-SCH. This fact might imply that only decreasing 
the point allocation of inversely correlated symptoms of 
the BPRS could also heighten the linearity of the BPRS. 
However, as was said before, the reproducibility of point 
allocation is quite uncertain in this model. Therefore, a 
randomized prospective study of this question in the fu- 
ture is desirable. 
Sixth, the modification of point allocation may have 
contributed some artifacts of multi-collinearity. There are 
likely to be inter-correlations among the data. In this 
study, variables that were inversely correlated with the 
CGI-SCH score, indicating that the more severe the 
BPRS item, the lower the CGI-SCH score (a phenome- 
non that was a departure from the clinicians’ experi- 
ences), were decreased in an ad hoc procedure. Addi- 
tional unknown and complicated factors are predicted to 
exist as well; for example, that both inpatients and outpa- 
tients were evaluated by the CGI-SCH and that the re- 
sults might have been negatively influenced by differ- 
ences in cognitive ability [34]. 
Seventh, we consider that our model is only applicable 
for a pair of scales where one is a single score scale (e.g., 
the CGI-SCH) and the other is a plural score scale (e.g., 
the BPRS). The condition that those two scales are in- 
tended for the same state of illness and are in a positive 
relationship intrinsically, at least roughly, is presumed 
necessary. Otherwise, if the two are in an inverse rela- 
tionship, for instance, as is the case between the CGI- 
SCH and the Global Assessment of Functioning (GAF) 
[8], the method we discussed might be expected to pro- 
duce nothing. 
Eighth, the range of scores from 1 to 7 on the CGI- 
SCH may have been narrow and floor and ceiling effects 
should not have been ignored. This problem would be 
remedied by prospective research to obtain a normally- 
distributed data set. In relation to details of the form of 
the scales, we speculate that a more precise way ap- 
proached from another viewpoint might be possible, for 
example, utilizing a visual analogue scale (VAS) [35-39] 
or a numerical rating scale (NRS) [40,41] for the ratings 
by psychiatrists, both of which range from 0 to 10, for 
the scores that we substituted for the clinical impression 
(although the true estimation of their validity is in flux at 
present [42-48]). We chose instead the ordinal CGI-SCH 
scores, which range ordinarily from 1 to 7 (taking “0” as 
“not assessed”), to express the clinicians’ global impress- 
sion of illness with schizophrenic patients. S. Stevens 
proposed a “ratio scale” on which four arithmetic opera- 
tions could be possible [49]. As the “0” of the BPRS and 
of the CGI-SCH means “not assessed”, these might pro- 
duce differences from the ordinal meaning of “0” (none) 
of the “ratio scale”. If so, the difference between the defi- 
nitions of “0” might cause a distortion for the BPRS and 
the CGI-SCH. As we commented previously, the possi- 
ble absence of linearity and of equal increments between 
each point of the CGI-SCH are serious problems that 
could not be ignored. In addition, the individual scores of 
the BPRS should ideally correspond to a visual analogue 
scale whose respective score ranges of 0 - 7 or 0 - 10 
would have a more adequate degree of linearity than the 
CGI-SCH. If this condition were met, the BPRS would 
become one of the more linear evaluating scales. 
Ninth, the modified 18-item BPRS should be regarded 
as a result based on mixed data from acute phase and 
chronic phase schizophrenic subjects. This origin might 
yield various types of biases and inadequate impressions 
(e.g., peculiar items that are likely to be observed strongly 
only in an acute or a chronic phase might be included in 
the modified scale presented in Figure 5). To define the 
“acute” or “chronic” phase of schizophrenia clearly was 
too complex and difficult an issue, so, ideally, the proto- 
type we proposed tentatively in Figure 5 should be re- 
determined as several scales, one each for the acute phase, 
the chronic phase and others phases, through more rig-
orous definitions for various phases of schizophrenia, by 
way of prospective ratings. 
Tenth, and above all, these results are not likely to be 
reproducible and our model has a meaning only for 
comparison purposes within a given study. If we per- 
formed the same procedure on new data, it is very likely 
that different point allocations would be assigned to indi- 
vidual items. We infer that a possible way to remedy this 
problem, even if partially, might be to perform a number 
of prospective trials in line with our method, and then 
summarize and calculate an average on items and point 
allocation. If these scales are composed as a summary, 
they might be less problematic than that of our trials. 
However, even in such scales, there would still be no 
assurance that they would have a greater degree of re- 
producibility. Therefore, the extent to which the results 
of this paper could be applicable may be quite limited. 
For this reason, future studies are necessary. 
Eleventh, the problem that we have addressed may be 
insoluble in principle. This approach to optimizing many 
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parameters (variables) so that a certain value would be 
maximized might not always provide the ideal magni- 
tudes for the other values. The challenge of the setting of 
this study was to find the optimized value of individual 
symptoms whose severities were recognized independ- 
ently when they were rated. If the solution of these kinds 
of problems, in which many values should be determined 
ideally at the same instant under the condition that a cer- 
tain parameter (e.g., Pearson’s r) would take the maxi- 
mum value, is impossible in principle, the applications 
might then be quite limited. 
The true aim of the present study was not always to 
determine the best point allocation, but to consider a spe- 
cific example of a potential modified BPRS through 
pursuing “the ideally modified BPRS” reflecting an ab- 
stract “true score”. Therefore, “the modified 18-item 
BPRS” is merely a tentative idea at this stage to propose 
a new viewpoint of the importance of point allocation in 
the BPRS. The present study has many limitations and is 
thus only a half-step from which further studies may 
learn. We believe that improving evaluation scales to 
make them more linear could minimize distortions in 
evaluations for severity of illness, including over- and 
under-diagnosis and estimations for efficiency and effect 
in clinical research. We anticipate that our present results 
will serve as a useful reference for clinicians attempting 
to devise an evaluation scale, and that further research 
will focus on the optimal number of items, the fittest 
items for selection, and the allocation of marks in a rig- 
orous methodology to maximize the linearity of the 
BPRS. 
5. Conclusion 
Within the limits of our data, a roughly logarithmic rela- 
tionship was discerned between the two scales and the 
item-weightings of the BPRS (apart from item-selection) 
were identified as important for the improvement of the 
BPRS for evaluating schizophrenia. 
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